Retatrutide has emerged as a new treatment in the fight against obesity. This novel drug, categorized as a dual GLP-1 and GIP receptor agonist, shows promising results in clinical trials. By boosting these receptors, https://izaakuwkc793604.slypage.com/36842928/setmelanotide-a-promising-new-treatment-for-obesity